The heptahelical G protein-coupled receptors (GPCRs) must reach their correct subcellular location to exert their function. Receptor domains relevant for receptor trafficking include signal sequences mediating receptor integration into the membrane of the endoplasmic reticulum (ER) and anterograde or retrograde transport signals promoting receptor sorting into the vesicles of the secretory pathway. In addition, receptors must be correctly folded to pass the quality control system of the early secretory pathway. Taking the endothelin B receptor as a model, we describe a new type of a transport-relevant GPCR domain. Deletion of this domain (residues Glu 28 to Trp 54 ) leads to a fully functional receptor protein that is expressed at a lower level than the wild-type receptor. Subcellular localization experiments and glycosylation state analyses demonstrate that the mutant receptor is neither misfolded, retained intracellularly, nor misrouted. Fluorescence recovery after photobleaching analyses demonstrate that constitutive internalization is also not affected. By using an in vitro prion protein targeting assay, we show that this domain is necessary for efficient translocon gating at the ER membrane during early receptor biogenesis. Taken together, we identified a novel transportrelevant domain in the GPCR protein family. Our data may also be relevant for other GPCRs and unrelated integral membrane proteins.
G protein-coupled receptors (GPCRs) play an important role in transmembrane signaling and are important drug targets. The GPCRs binding the endothelins (ET-1, ET-2, and ET-3) are important physiological regulators in the vascular system. Two endothelin receptor subtypes are known: the endothelin A receptor (ET A R), expressed mainly in vascular smooth muscle cells; and the endothelin B receptor (ET B R), expressed mainly in endothelial cells (Arai et al., 1990; Sakurai et al., 1990) . Whereas the ET A R stimulates G proteins of the G q/11 and G 12/13 families, the ET B R couples to G i and G q/11 (Eguchi et al., 1993; Cramer et al., 2001) . The ET A R elicits a long-lasting contraction of vascular smooth muscle cells via an increase in cytosolic Ca 2ϩ concentrations and activation of Rho proteins (Seo et al., 1994; Seko et al., 2003) . The ET B R stimulates the release of NO and prostacyclin in endothelial cells, thereby causing the relaxation of vascular smooth muscle cells (de Nucci et al., 1988) .
To accomplish all of these functions, GPCRs must be transported along the secretory pathway to their correct location. Several GPCR domains are relevant for intracellular trafficking. First, signal sequences (von Heijne, 1985 (von Heijne, , 1990 Higy et al., 2004) either are located at the N terminus of the proteins and cleaved off after ER insertion (signal peptides), or form part of the mature protein (signal anchor sequence; usually the first transmembrane domain). These sequences mediate the integration of the receptors into the membrane of the ER during early receptor biogenesis (Osborne et al., 2005; Wickner and Schekman, 2005) . Second, anterograde or retrograde transport signals may promote receptor sorting into the vesicles of the secretory pathway (Bethune et al., 2006; Gurkan et al., 2006) . Finally, some conserved sequences, such as hydrophobic motifs in the C tail, seem to be relevant for a transport-competent folding state (Schü lein et al., 1998; Pankevych et al., 2003) . Mutation of these motifs leads to misfolded forms that are retained intracellularly by the quality control system of the early secretory pathway. These proteins are finally subjected to proteolysis by the ER-associated degradation pathway (ERAD) (Schwieger et al., 2008) .
Endothelin receptors belong to the small subgroup of GPCRs possessing cleavable N-terminal signal peptides for ER insertion (Wallin and von Heijne, 1995; Köchl et al., 2002) . Similar to secretory proteins, these signal peptides are recognized shortly after their synthesis by the signal recognition particle (SRP) and mediate the transfer of the ribosome/nascent chain/SRP complex to the translocon complex at the ER membrane (Walter and Johnson, 1994; Shan and Walter, 2005) . After a GTP-dependent interaction between the SRP and the SRP receptor, the signal peptides and adjacent N-tail sequences engage the protein-conducting Sec61 channel of the translocon complex in a hairpin conformation. Accessory components, such as the translocating chain associating membrane protein (Görlich et al., 1992; Görlich and Rapoport, 1993) or the translocon-associated protein complex (Hartmann et al., 1993; Fons et al., 2003) , are also involved in signal recognition. The signals then switch the Sec61 channel from the closed to the open configuration, thereby mediating not only ER targeting of nascent chains but also translocon gating (Jungnickel and Rapoport, 1995; Belin et al., 1996; Osborne et al., 2005) .
Whereas the role of signal peptides in translocon gating is well established, the significance of the adjacent N tail sequences following the signal peptide, which also encounter the Sec61 channel, has been unclear. We have addressed this question and show that these residues are necessary for efficient translocon gating in the case of the ET B R.
Materials and Methods
Materials. The PrP(A120L) reporter cassette has been described previously (Kim et al., 2002) . [
125 I]ET-1 (2000 Ci/mmol) was purchased from GE Healthcare (Freiburg, Germany). Lipofectamine 2000 and the vector pSecTag2A were purchased from Invitrogen (Karlsruhe, Germany). The vector plasmid pEGFP-N1 (encoding the red-shifted variant of GFP) and the plasmid pEYFP-Endo were from Clontech (Mountain View, CA). The transfection reagent FuGENE HD was from Roche Diagnostics (Mannheim, Germany). DNA-modifying enzymes PNGaseF and EndoH were from New England Biolabs (Frankfurt am Main, Germany). Oligonucleotides were purchased from Biotez (Berlin, Germany). Trypan blue and Rhodamine 6G were purchased from Seromed (Berlin, Germany). The RotiLoad sample buffer was from Carl Roth (Karlsruhe, Germany). The polyclonal rabbit anti-GFP antiserum 01 (raised against a GST-GFP fusion protein) has been described previously (Alken et al., 2005) . The monoclonal mouse anti-GFP antibody was purchased from Clontech Laboratories (Heidelberg, Germany). Alkaline phosphatase-conjugated anti-mouse IgG was purchased from Dianova (Hamburg, Germany). All other reagents were from Sigma (Taufkirchen, Germany). The materials for the prion protein targeting assay were described previously (Kim et al., 2002) . DNA Manipulations. Standard DNA manipulations were carried out according to the handbook of Sambrook and Russell (2001) . Nucleotide sequences of the plasmid constructs were verified using the FS Dye Terminator kit from PerkinElmer Life and Analytical Sciences (Köln, Germany). Site-directed mutagenesis was carried out with the QuikChange Site-Directed Mutagenesis Kit from Stratagene (Heidelberg, Germany).
Plasmid Constructs. Constructs used in this study are schematically shown in Fig. 1A (details of the cloning procedures are available on request). The sequence of the N-tail of the ET B R is depicted in Fig. 1B . Regarding the full-length receptor constructs, Plasmid pET B .GFP encodes the ET B R in the vector plasmid pEGFP-N1 (Oksche et al., 2000) . The receptor is C-terminally tagged with a GFP moiety (thereby deleting the stop codon of the receptor). In plasmid pET B .⌬27.GFP, the sequence Glu 28 to Trp 54 (27 residues) of the mature N-tail of the ET B R was deleted. (Kim et al., 2002) . In plasmid ET B .SP28.PrP, residues Glu 27 to Trp 54 (28 residues) were added C-terminal of the signal peptide, thereby replacing 28 amino acid residues of the PrP sequence. Cell Culture and Transfection. Cells were cultured at 37°C and 5% CO 2 . HEK 293 cells were grown in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal calf serum, penicillin (100 U/ml), and streptomycin (100 g/ml). Transfection of the cells with plasmids and Lipofectamine 2000 or FuGENE HD was carried out according to the supplier's recommendations. Equal amounts of plasmid were transfected in each experiment to allow for the comparison of the receptor expression levels.
Confocal Laser Scanning Microscopy. HEK 293 cells (2.5 ϫ 10 5 ) grown for 24 h in a 35-mm diameter dish containing a poly(Llysine)-coated coverslip were transfected with 1 g of plasmid DNA and FuGENE HD according to the supplier's recommendations. Cells were incubated overnight, washed once with PBS, and transferred immediately into a self-made chamber (details are available on request).
For the colocalization of the receptor GFP signals with plasma membrane Trypan blue signals (Schü lein et al., 1998) , live cells were covered with 1 ml of PBS, and Trypan blue was added to a final concentration of 0.05%. After 1 min of staining, GFP and Trypan blue signals were visualized at room temperature using a Zeiss LSM510-META invert confocal laser-scanning microscope (objective lens, 100ϫ/1.3 oil; optical section: Ͻ0.9 m; multitrack mode: GFP, exc : 488 nm, argon laser, BP filter: 500-530 nm; Trypan blue, exc : 543 nm, HeNe laser, LP filter: 560 nm; Carl Zeiss GmbH, Jena, Germany). The overlay of both signals was computed using the Zeiss LSM510 software (release 3.2). Images were imported into Photoshop software (release 6.0; Adobe Systems Inc., San Jose, CA), and contrast was adjusted to approximate the original image.
To quantify GFP signals, the signal intensities at the plasma membrane and in the cell's interior were measured using the eightbit gray scale (ranging from 0 to 250) provided by the LSM510 software. Total GFP fluorescence intensity of cells (n ϭ 16-27 cells) or the ratio of plasma membrane and intracellular signals was determined.
For Rhodamine 6G staining of the ER (Schü lein et al., 1998) , live cells expressing the receptor constructs were washed with PBS and incubated for 40 min with 50 nM Rhodamine 6G in PBS. The receptor GFP signals and the ER Rhodamine 6G signals were analyzed by confocal LSM (objective lens: 100ϫ/1.3 oil; optical section: Ͻ0.9 m; multitrack mode: GFP, exc : 488 nm, argon laser, BP filter: 494-516 nm; Rhodamine 6G, exc : 543 nm, HeNe laser, LP filter: 560 nm) and processed as described above.
For FRAP experiments, a maximal laser intensity ( exc ϭ 488 nm) with 50 iterations was used to bleach the selected ROIs in the cells.
Images were recorded in a time series of 1650 s with an interval of 150 s (only the pictures after 0, 150, 300, 900, and 1650 s are shown). Live cell imaging of GFP fluorescence signals and image processing were performed as described above. Fluorescence measurements in the ROIs and statistical analyses (n ϭ 6-8 cells) were performed using the eight-bit gray scale of the LSM510 software. Mean values were fitted using the Prism software (release 3.02; GraphPad Software Inc., San Diego, CA) and the equation I(t) ϭ Max ϩ (Min Ϫ Max) ϫ exp(Ϫt/T), where I(t) is time dependency of fluorescence intensity; Max is fluorescence intensity at the end of recovery (maximum); Min is fluorescence intensity after photobleaching (minimum); t is time; and T is half-life. Mean values were expressed as the percentage of the initial value.
Northern Blot. The experiment was carried out essentially as described previously (Alken et al., 2005 4 ) grown on poly(L-lysine)-coated 96-well plates. Cells were washed twice with 100 l of binding buffer consisting of PBS-I (0.9 mM CaCl 2 , 0.5 mM MgCl 2 , 2.7 mM KCl, 136.9 mM NaCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , 0.5 mM PMSF, 0.5 mM benzamidine, 3.2 g/ml trypsin inhibitor, 1.4 g/ml aprotinin, 0.2 mg/ml bacitracin, and 0.05% bovine serum albumin, pH 7.4). [
125 I]ET-1, diluted in 100 l of the same buffer, was added to achieve the indicated concentrations. Nonspecific binding was determined in the presence of 1 M unlabeled ET-1. Cells were incubated with the ligand for 2 h on ice (to avoid receptor internalization), washed quickly two times with ice-cold PBS-I, and lysed with 100 l of 0.1 N NaOH. The lysate was transferred to tubes, and radioactivity was measured using a ␥ counter. For the inositol phosphate accumulation assay, the experiment was carried out with intact transiently transfected HEK 293 cells as described previously for stably transfected HEK 293 cells (Wietfeld et al., 2004) . All data were analyzed using the Prism software (release 3.02).
Immunoprecipitation of GFP-Tagged ET B R Deletion Constructs and Immunoblotting. HEK 293 cells (4 ϫ 10 6 ), grown on 100-mm diameter dishes, were transiently transfected with 10 g of plasmid DNA and FuGENE HD according to the supplier's recommendations. Cells were cultivated for 24 h, washed twice with PBS, pH 7.4, and lysed for 1 h with 1 ml of lysis buffer [50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 0.1% (w/v) SDS, 1% (v/v) Triton X-100, pH 8.0, supplemented with 0.5 mM PMSF, 0.5 mM benzamidine, 1.4 g/ml aprotinin, and 3.2 g/ml trypsin inhibitor]. Insoluble debris was removed by centrifugation (20 min, 13,000g). The supernatant was supplemented with polyclonal rabbit anti-GFP antiserum 01 coupled to protein A Sepharose Cl-4B beads, and the sample was incubated over night (beads were prepared by equilibrating 10 mg of the beads with lysis buffer and subsequent overnight incubation with 2 l of polyclonal rabbit anti-GFP antiserum 01). GFP-tagged 
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at ASPET Journals on October 13, 2017 molpharm.aspetjournals.org receptors were precipitated (2 min, 700g), and the beads were washed twice with 2 ml of washing buffer 1 [50 mM Tris-HCl, 500 mM NaCl, 1 mM EDTA, 0.1% (w/v) SDS, and 0.5% (v/v) Triton X-100, pH 8.0] and once with 2 ml of washing buffer 2 [50 mM Tris-HCl, 1 mM EDTA, 0.1% (w/v) SDS, and 1% (v/v) Triton X-100, pH 7.4]. Precipitated receptors were treated with EndoH or PNGaseF according to the supplier's recommendations or left untreated. Samples were supplemented with RotiLoad sample buffer, incubated for 5 min at 95°C, and analyzed by SDS-PAGE/immunoblotting (10% SDS) using a monoclonal mouse anti-GFP antibody and alkaline phosphatase-conjugated anti-mouse IgG. Immunoblots were carried out as described previously (Kyhse-Andersen, 1984) .
Prion Protein Targeting Assay. In vitro transcription with SP6 RNA polymerase was performed for 1 h at 40°C. Translation with rabbit reticulocyte lysate in the presence of [
35 S]methionine, and translocation into canine rough microsomal membranes were carried out at 40°C for 40 min as described previously (Kim et al., 2001 (Kim et al., , 2002 . Proteinase K (PK) digestion (0.5 mg/ml) was performed for 60 min at 0°C; reactions were terminated with 5 mM PMSF. The Nglycosylation acceptor site inhibitor peptide (peptide sequence ϭ NH 2 -Asp-Tyr-Thr-COOH) was used in a concentration of 160 M in all samples to inhibit N-glycosylation of the prion protein moieties thereby facilitating interpretation of the results. Triton X-100 (1%) was used to permeabilize membranes. All samples were transferred into 10 volumes of a preheated solution containing 1% SDS and 0.1 M Tris-HCl, pH 8.0, and analyzed by SDS-PAGE on 12% Tris/Tricine gels. Proteins were visualized by autoradiography.
Results

Deletion of the Sequence Glu
28 to Trp 54 Decreases ET B R Expression without Causing Misfolding, Intracellular Retention, Misrouting, or Increased Constitutive Internalization of the Receptor. We used the previously described GFP-tagged construct ET B .GFP for our work (Fig. 1A) (the GFP tag does not influence the pharmacological or trafficking properties of the receptor) (Oksche et al., 2000) . To study the significance of the sequence after the signal peptide for receptor trafficking, a deletion mutant was constructed by eliminating the sequence encoding residues Glu 28 to Trp 54 (Fig. 1A, construct To preclude an influence of the deletion on mRNA synthesis, a Northern blot analysis with total RNA derived from transiently transfected HEK 293 cells was performed (Fig. 2) . For ET B .GFP and ET B ⌬27.GFP, RNA bands of 2.0 and 1.9 kilobases were detected, respectively (the smaller size in the case of mutant ET B ⌬27.GFP is due to the deletion). Both transcripts were present in similar amounts, demonstrating that the deletion has no influence on mRNA synthesis and stability.
We next compared the pharmacological properties of the constructs ET B .GFP and ET B ⌬27.GFP. HEK 293 cells were transiently transfected, and [
125 I]ET-1-binding profiles of intact cells were recorded (Fig. 3A) (Fig. 3B) . The EC 50 values were 4.5 Ϯ 0.1 nM for ET B .GFP versus 3.3 Ϯ 0.1 nM for ET B ⌬27.GFP, indicating that the deletion mutant has normal signaling properties. The decreased number of ET B ⌬27.GFP receptors is nevertheless sufficient to achieve almost maximal adenylyl cyclase stimulation as a result of a receptor reserve in the transfected cells. Taken together, these results demonstrate that the Glu 28 to Trp 54 deletion does not influence the pharmacological properties of the ET B R but decreases receptor expression at the plasma membrane.
Deletion of the Glu 28 to Trp 54 sequence does not involve the signal peptide itself. It is also unlikely that the deletion affects a transport signal because these are located in intracellular domains of integral membrane proteins allowing direct or indirect binding of vesicular coat components. Although the K D and EC 50 values of the mutant ET B ⌬27.GFP are similar to those of the wild type, indicating that the mutant receptor is correctly folded, the deletion may nevertheless lead to a subtle change in receptor conformation, which may be recognized by the quality control system of the ER and/or other components of the early secretory pathway. In this case, the mutant receptor would be initially retained in the early secretory pathway and finally subjected to proteolysis by the ERAD (Schwieger et al., 2008) . Such a behavior of mutant ET B ⌬27.GFP may explain the decreased number of receptors at the plasma membrane. GPCR retention in the early secretory pathway and subsequent degradation by the ERAD is accompanied by a decrease in the ratio of complex and high mannose-glycosylated receptors (Schü lein et al., 1998; Robben et al., 2005; Schwieger et al., 2008) ; the complex-glycosylated forms represent the mature receptors, and the high mannose forms represent the immature forms present in the early secretory pathway.
To address changes in steady-state glycosylation, (Fig. 4, a and Retention of a mutant receptor by the quality control system and subsequent degradation by the ERAD is also accompanied by a steady-state accumulation of the receptor in the early secretory pathway, which is detectable microscopically (e.g., Schü lein et al., 1998; Robben et al., 2005; Schwieger et al., 2008) . To confirm the results that ET B ⌬27.GFP is not subjected to a more stringent quality control in the early secretory pathway, we analyzed the subcellular location of the GFP signals of the receptor by confocal LSM and assessed their colocalization with the plasma membrane dye Trypan blue (Fig. 5A , top) (Schü lein et al., 1998) or the ER dye Rhodamine 6G (Fig. 5A , bottom) (Schü lein et al., 1998) in transiently transfected HEK 293 cells. In the case of a folding defect causing receptor retention and subsequent ERAD degradation, a decrease in the amount of plasma membrane receptors should lead to a concomitant increase in the (Schü lein et al., 1998) . Analysis of the GFP signals of the constructs revealed a significantly reduced overall expression of ET B ⌬27.GFP in comparison to ET B .GFP. However, the subcellular distribution of ET B ⌬27.GFP and ET B .GFP was similar, and no increase in Rhodamine 6G colocalization was observed for ET B ⌬27.GFP. In addition, we have quantified and statistically analyzed the GFP signals of ET B ⌬27.GFP and ET B .GFP. The total fluorescence (i.e., the sum of intracellular and plasma membrane signals) was significantly reduced in the case of ET B ⌬27.GFP, demonstrating a decrease in receptor expression to 38% of the wild-type level (Fig. 5B, left) . The ratio of intracellular and plasma membrane fluorescence, however, was unchanged, again demonstrating that retention of the mutant in the early secretory pathway is not increased (Fig. 5B, right) . These data are entirely consistent with the pharmacological data, glycosylation state analyses, and limited proteolysis experiments.
The reduced amount of cell surface receptors in the case of ET B ⌬27.GFP may also result from an increase in constitutive internalization (removal from the cell surface without ligand stimulation). To address this question, we performed FRAP experiments with transiently transfected HEK 293 cells expressing ET B ⌬27.GFP and ET B .GFP. Endosomal compartments of the cells containing receptors were identified by colocalizing the receptor's GFP signals with those of the cotransfected endosomal marker protein pEYFP-Endo (data not shown). ROIs were selected by confocal LSM, and the endosomal compartments were bleached with maximal laser intensity (Fig. 6A) . Refilling of the ROIs with receptor GFP signals was recorded in a time series of 1650 s with an interval of 150 s (only the pictures after 0, 150, 300, 900, and 1650 s are shown in Fig. 6A) . Quantification of the timedependent refilling of the photobleached endosomal compartments yielded almost identical curves for ET B ⌬27.GFP and ET B .GFP, demonstrating that constitutive internalization of the mutant is not affected by the mutation.
Taken together, deletion of residues Glu 28 to Trp 54 of the ET B R decreases overall receptor expression substantially. Neither receptor misfolding, increased retention/ERAD degradation, misrouting, nor an increased constitutive internalization was detectable. Thus, our data indicate that the Glu 28 to Trp 54 sequence facilitates, like the signal peptide itself, an early step in receptor biogenesis such as translocon gating. Such a function is reasonable, because the sequence after the signal peptide also encounters the Sec61 channel during the hairpin insertion mechanism.
The Sequence Glu 28 to Trp 54 of the N-Tail of the ET B R Is Required for Efficient Translocon Gating. An efficient method has been described for secretory proteins to measure the translocon gating properties of their signal peptides and consequently that of adjacent sequences, using the PrP(A120L) protein as a marker (Kim et al., 2001 (Kim et al., , 2002 . The PrP(A120L) reporter is a modified version of the PrP hamster prion protein lacking its N-terminal signal peptide (Fig. 7A) . The remaining single hydrophobic transmembrane domain of this construct is unable to mediate ER targeting, making efficient translocation of the protein at the ER membrane dependent on the introduction of a signal peptide. In this system, [
35 S] methionine-labeled fusion proteins are synthesized in the presence of canine pancreatic rough microsomal membranes (RMs) using an in vitro rabbit reticulocyte lysate translation system. Nascent chains containing signal peptides failing to target to the ER membrane and/or failing to promote binding to the translocon result in exclusive cytosolic and completely PK-sensitive translation products (Fig.  7A, step 1) . In contrast, signal peptides targeting the nascent chains to the translocon lead to the integration of the fusion proteins into the ER membrane (Fig. 7A, step 2) . Two different orientations of the fusions are possibly dependent on the gating properties of the signal peptide: if the signal peptide initiates the access to the luminal environment efficiently, (Fig. 7A, step 3.1, ϭ N exo -C cyt form) of the construct is synthesized, and the signal peptide is cleaved off after translocation. Complete translocation of the construct into the ER lumen may also take place in this case ( Fig. 7A ; step 3.1, Lu form). If, however, the signal peptide opens the translocon inefficiently, the TM of the PrP(A120L) reporter takes over the gating function, and the Ctm form (Fig. 7A,  step 3 .2, ϭ N cyt -C exo form) with an uncleaved signal peptide is synthesized. Ntm or Ctm forms can be distinguished by a protease protection assay, the resulting Ntm fragment being smaller than the Ctm fragment.
To address the question of whether the sequence after the signal peptide of the ET B R facilitates translocon gating, we introduced the signal peptide of the ET B R alone and together with its adjacent Glu 27 to Trp 54 sequence into the PrP(A120L) marker protein, thereby replacing the original PrP sequences (Fig. 1A; constructs ET B .SP.PrP and ET B .SP28.Pr, respectively). The total number of amino acids remained constant in each construct. In vitro synthesis of the ET B .SP.PrP construct in the presence of RMs led mainly to the formation of one major protein band on the gel after autoradiography, representing the Ctm form of the construct with its uncleaved signal peptide (Fig. 7B , lane 1, "Ctm"; see the bottom of Fig. 7B for the interpretation of the results). The fact that this band represents the Ctm form could be concluded from the apparent molecular mass of the resulting fragment in the PK protection assay (Fig. 7B, lane 3 , "Ctm-d") (Kim et al., 2002) .
If the adjacent Glu 27 to Trp 54 sequence of the ET B R is additionally fused (replacing 28 residues of PrP; construct ETB.SP28.PrP; see Fig. 1A ), different results are obtained. In vitro synthesis in the presence of RMs yields two bands (Fig. 7B, lane 2) . The lower, stronger band represents both the mature Ntm form ("Ntm") and the translocated luminal ("Lu") form sharing the same apparent molecular mass. The top faint band represents the precursor ("Pre") of both the Ntm and luminal forms still possessing the signal peptide (this band is detectable in variable amounts from experiment to experiment and was omitted in the interpretation of the results in the bottom of Fig. 7B ). The identity of Lu and Ntm forms could again be derived from the PK protection assay, the Lu form being completely resistant to PK digestion, the Ntm form being digested to the corresponding low molecular mass fragment (compare with the Ctm-d fragment of ETB-SP.PrP, lane 3; Fig. 7B , lane 4, "Ntm-d") (Kim et al., 2002) .
Taken together, the presence of the ET B .SP.PrP construct in its Ctm form in the RMs demonstrates that the signal peptide of the ET B R alone is sufficient for ER targeting but not for efficient translocon gating. Only if the Glu 28 to Trp 54 sequence of the ET B R is additionally present, Ntm and Lu forms indicating efficient translocon opening are detectable.
The recently published structure of the canine Sec61 protein (Ménétret et al., 2008) revealed the presence of a 22 Å wide cavity in the closed conformation of the protein-conducting channel. When a helical structure model of the signal peptide of the ET B R (26 amino acids) is inserted into this cavity above the channel-sealing plug domain (Fig. 8) , it is obvious that the channel may not only incorporate the signal peptide and an adjacent domain of similar length, which may help to gate the channel, but also additional sequences. This raises the question of whether the Glu 28 to Trp 54 sequence must directly follow the signal peptide or whether it may be located more C-terminally. (Fig. 9A) . Colocalization of the receptor's GFP signals with the plasma membrane marker Trypan blue by confocal LSM (Fig. 9B) and quantification of the (blue, hydrophilic; green/brown, hydrophobic) . Spatial dimensions are indicated in angstroms (white arrows). A helical structure model of the signal peptide of the ET B R is inserted into the channel cavity (yellow, amino acids 6 -26) above the plug segment (orange), which seals the channel . The structure was adapted from Ménétret et al. (2008) and the corresponding entry in the Protein Data Bank (code 3DKN, backbone white-gray).
membrane-bound GFP signals (Fig. 9C) 
GFP).
Gating is completely prevented when the signal peptide is fused directly to a PrP sequence (construct ET B .PrP). In conclusion, the gating properties of the signal peptide seem A similar protein-specific match of signal peptide and mature domain functions has recently been proposed for secretory proteins (Kim et al., 2002) . In these studies, signal peptide-mediated gating was also related to the adjacent sequences and decreased upon exchange of the original mature domain, although the size of the domain responsible for this effect had not been determined (Kim et al., 2002) . Our results indicate that the same applies to the ET B R and potentially to other GPCRs and integral membrane proteins possessing cleavable signal peptides. Taking the data for secretory proteins and our results together, it may be speculated that signal peptides and their adjacent sequences represent functional units, allowing efficient translocon gating only in the original combination.
The mechanism by which the Glu 28 to Trp 54 sequence of the ET B R facilitates translocon gating remains elusive. Signal peptide-mediated relocation of the plug domain occluding the Sec61 channel (van den Berg et al., 2004 ) may be facilitated by an associated or, in contrast, by a nonassociated combination of signal peptide and assisting sequence when encountering the channel in a hairpin mechanism (Fig. 10 a  and b, respectively) . Interactions of Glu 28 to Trp 54 with the translocon-associated protein complex may also play a role because it has been shown that this complex is involved in signal peptide-mediated transclocon gating, at least in the case of some signal peptides (Fons et al., 2003) . The expression data of mutant ET B Ins.GFP (Fig. 9) indicate that a domain assisting in translocon gating must not directly follow the signal peptide. Taking the spatial dimensions within the Sec61 channel into account (Fig. 8) , it is obvious that its cavity can also accept assisting domains, which are located more C-terminally, consequently forming larger hairpin structures.
Our data also raise the question of whether the Glu 28 to Trp 54 sequence represents a conserved domain in the GPCR protein family. Signal peptides of different proteins have a common secondary structure but no sequence homologies (von Heijne, 1985 (von Heijne, , 1990 . Thus, if signal peptides and assisting N-tail sequences form indeed a functional unit during translocon gating, it is unlikely that the respective N-tail sequences have sequence homologies. In agreement with this view, we did not find sequences in the N-tails of GPCRs, which are homologous to the Glu 28 to Trp 54 sequence (data not shown).
The structural analysis of GPCRs is an important and difficult task, and it has been frequently tried to increase GPCR expression by the fusion of signal peptides, particularly in the case of those GPCRs that do normally contain uncleaved signal anchor sequences (Guan et al., 1992; Grisshammer et al., 1993 , Grü newald et al., 1996 Kempf et al., 2002) . However, the outcome of these experiments was not predictable, and signal peptide-mediated increase in expression was not obtained regularly. Taking our data into account, it is conceivable that an increase in expression might only be achieved when a signal peptide is fused to an N-tail domain matching the requirements of the signal peptide. Another conclusion from our data is that care should be taken when GPCRs possessing signal peptides are modified in their extreme N tail, for example, by fusing tags to facilitate protein detection, because these modifications may have a strong impact on protein expression. 
